Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanox Japan appears to be the Japanese operating unit of Nanox, the publicly traded medical imaging company developing and commercializing digital multi-source 3D tomosynthesis systems, AI-enabled imaging analytics, cloud software, and radiology services. The Japan operation has been associated with development of Nanox's cold-cathode digital X-ray source technology and has been led publicly by Hitoshi Masuya. Nanox's broader platform includes the Nanox.ARC and Nanox.ARC X imaging systems, Nanox.AI software, Nanox.CLOUD infrastructure, and radiology workflow services. Based on available public information, Nanox Japan is healthcare-related and active, but it does not appear to operate as a separately listed standalone biotech or pharmaceutical company with a drug pipeline. Its role is best understood as a regional subsidiary or operating entity supporting Nanox's imaging technology and commercialization efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanox Japan.